International Flavors & Fragrances Inc. (IFF) Q2 2026 Earnings Call Transcript

SA Transcripts 161.51K Followers Follow International Flavors & Fragrances Inc. ( IFF ) Q2 2026 Earnings Call August 5, 2026 9:00 AM EDT Company Participants Michael Bender - Director of Investor Relations Jon Erik Fyrwald - CEO & Director Michael Deveau - Executive VP & CFO Conference Call Participants Abigail Eberts - Wells Fargo Securities, LLC, Research Division Kristen Owen - Oppenheimer & Co. Inc., Research Division Ghansham Panjabi - Robert W. Baird & Co. Incorporated, Research Division David Begleiter - Deutsche Bank AG, Research Division Lauren Lieberman - Barclays Bank PLC, Research Division Ming Tang - BNP Paribas, Research Division Laurence Alexander - Jefferies LLC, Research Division Patrick Cunningham - Citigroup Inc., Research Division John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Joshua Spector - UBS Investment Bank, Research Division Lisa Hortense De Neve - Morgan Stanley, Research Division Kevin McCarthy - Vertical Research Partners, LLC Matthew DeYoe - BofA Securities, Research Division Christopher Parkinson - Wolfe Research, LLC Presentation Operator At this time, I would like to welcome everyone to the IFF Second Quarter 2026 Earnings Conference Call. [Operator Instructions] I would now like to introduce Michael Bender, Head of Investor Relations. You may begin. Michael Bender Director of Investor Relations Thank you. Good morning, good afternoon and good evening, everyone. Welcome to IFF's Second Quarter 2026 Earnings Conference Call. Yesterday afternoon, we issued a press release announcing our financial results. A copy of the release can be found on our IR website at ir.iff.com. Please note that this call is being recorded live and will be available for replay. During the call, we'll be making forward-looking statements about the company's performance and business outlook. These statements are based on how we see things today and contain elements of uncertainty. For additional information concerning the factors that can cause actual results to differ materially, please refer to our cautionary statement and risk factors contained in our 10-K and press release, both